HIGH SUSCEPTIBILITY OF U937-DERIVED SUBCLONES TO INFECTION WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IS CORRELATED WITH VIRUS-INDUCED CELL-DIFFERENTIATION AND SUPEROXIDE GENERATION

被引:11
|
作者
KAMEOKA, M [1 ]
KIMURA, T [1 ]
OKADA, Y [1 ]
NAKAYA, T [1 ]
KISHI, M [1 ]
IKUTA, K [1 ]
机构
[1] HOKKAIDO UNIV,INST IMMUNOL SCI,SEROL SECT,KITA KU,SAPPORO,HOKKAIDO 060,JAPAN
来源
IMMUNOPHARMACOLOGY | 1995年 / 30卷 / 01期
关键词
HIV-1; DIFFERENTIATION; U937; LFA-1; SUPEROXIDE; PHORBOL 12-MYRISTATE 13-ACETATE (PMA);
D O I
10.1016/0162-3109(95)00012-I
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The promonocytic human leukemic cell line U937, when infected with lymphotropic human immunodeficiency virus type 1 (HIV-1), becomes a continuous virus producer. A total of 46 U937-derived subclones in suspension was isolated and classified into three (2 high, 42 middle, and 2 low) types based on their susceptibility to the infection. By analyzing subclones before infection, we found that the high-type subclones expressed LFA-1 antigens at a relatively low level. In addition, the ability of these subclones to induce adherence after exposure to phorbol 12-myristate 13-acetate (PMA) was reduced. In contrast, a transition by HIV-1 infection to adherent macrophage-like cells was induced only in the high-type, but not in the low-type subclones. The high-type adherent cells obtained by HIV-1 infection were followed by further lineage to become retrodifferentiated suspension cells showing reduced syncytia formation ability. Superoxide was generated in the high-type subclones, without PMA-mediated differentiation, from the early stage of infection before HIV-1 replication, as well as during undifferentiated, differentiated and retrodifferentiated stages. In contrast, it was only transiently generated at acute phase of HIV-1 replication in low-type subclones. Long-term culture of the low-type subclones decreased the expression of major structural viral protein Gag and also virus production. Thus, the mechanism by which PMA differentiates U937 cells is not the same as that induced by HIV-1 infection. The latter mechanism results in high susceptibility to infection. The HIV-1 phenotypes of finally obtained persistently infected cells were also affected by the cell stages at the time of infection.
引用
收藏
页码:89 / 101
页数:13
相关论文
共 47 条
  • [1] High susceptibility of U937-derived subclones to human immunodeficiency virus type 1 infection correlates with accumulation of unintegrated circular viral DNA
    Kameoka, M
    Kimura, T
    Okada, Y
    Fujinaga, K
    Nakaya, T
    Takahashi, H
    Kishi, M
    Ikuta, K
    VIRUS GENES, 1996, 12 (02) : 117 - 129
  • [2] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION IN A COMMUNITY OF SOUTHERN MOZAMBIQUE
    MENCARINI, P
    DELUCA, A
    GHIRGA, P
    VICHI, F
    ANTINORI, A
    MAIURO, G
    NOORMAHOMED, I
    TAMBURRINI, E
    TROPICAL AND GEOGRAPHICAL MEDICINE, 1991, 43 (1-2): : 39 - 41
  • [3] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION OF ENDOTHELIAL-CELLS INVITRO
    RE, MC
    FURLINI, G
    CENACCHI, G
    PREDA, P
    LAPLACA, M
    MICROBIOLOGICA, 1991, 14 (02): : 149 - 152
  • [4] Herpes Simplex Virus-Induced Epithelial Damage and Susceptibility to Human Immunodeficiency Virus Type 1 Infection in Human Cervical Organ Culture
    Horbul, Julie E.
    Schmechel, Stephen C.
    Miller, Barrie R. L.
    Rice, Stephen A.
    Southern, Peter J.
    PLOS ONE, 2011, 6 (07):
  • [5] VIRAL ACTIVATION FROM LATENCY DURING RETRODIFFERENTIATION OF U937 CELLS EXPOSED TO PHORBOL ESTER FOLLOWED BY INFECTION WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    OKADA, Y
    KIMURA, T
    KAMEOKA, M
    KISHI, M
    AZUMA, I
    IKUTA, K
    IMMUNOPHARMACOLOGY, 1995, 30 (01): : 27 - 39
  • [6] INTERFERON-GAMMA PROTECTS PRIMARY MONOCYTES AGAINST INFECTION WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    FAN, SX
    TURPIN, JA
    ARONOVITZ, JR
    MELTZER, MS
    JOURNAL OF LEUKOCYTE BIOLOGY, 1994, 56 (03) : 362 - 368
  • [7] DEVELOPMENT AND SIGNIFICANCE OF NUCLEOSIDE DRUG-RESISTANCE IN INFECTION CAUSED BY THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    SMITH, M
    SALOMON, W
    WAINBERG, MA
    CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE, 1994, 17 (03): : 226 - 243
  • [8] INHIBITION OF INFECTION OF T-CELLS WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 BY DIDEOXYNUCLEOSIDES CONJUGATED WITH OLIGOPEPTIDES
    SHIMIZU, NS
    HANDA, A
    SHIMIZU, NG
    IKEDA, R
    UCHIYAMA, T
    ACHIWA, K
    HOSHINO, H
    ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1995, 6 (01) : 17 - 24
  • [9] INVITRO INFECTION OF EPIDERMAL LANGERHANS CELLS WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HTLV-IIIB ISOLATE)
    DELORME, P
    DEZUTTERDAMBUYANT, C
    EBERSOLD, A
    DESGRANGES, C
    THIVOLET, J
    SCHMITT, D
    RESEARCH IN VIROLOGY, 1993, 144 (01): : 53 - 58
  • [10] INFECTION OF EPITHELIAL-CELL LINE HEP-2 WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IS CD4 DEPENDENT
    NOTTET, HSLM
    JANSE, I
    DEGRAAF, L
    BAKKER, LJ
    VISSER, MR
    VERHOEF, J
    JOURNAL OF MEDICAL VIROLOGY, 1993, 40 (01) : 39 - 43